Dasatinib poses significant medication risks in specific populations and requires strict evaluation before use. The following elaborates on the core contraindications from two aspects: absolute contraindications and drug interactions.
1、 Severe liver and kidney dysfunction patients
Severe liver dysfunction
Children with Pugh C grade or decompensated liver disease have severely reduced drug metabolism, which can easily lead to toxic accumulation. Unless the benefits clearly outweigh the risks, it is generally not recommended to use it.
Severe renal dysfunction
Patients with end-stage renal disease or requiring dialysis lack sufficient safety data. If medication is necessary, it should be reduced and adverse reactions should be closely monitored.
Alternative evaluation
The above-mentioned patients should weigh other treatment options under the guidance of a specialist physician and should not self medicate.
2、 The risk of combination therapy with potent CYP3A4 inhibitors
Explicitly prohibit combinations
Avoid co administration with potent CYP3A4 inhibitors such as clarithromycin, itraconazole, ketoconazole, and ritonavir, as this significantly increases the blood concentration of dasatinib and increases the risk of toxicity.
Alternative options
If it is necessary to use anti infective or antifungal drugs, non potent CYP3A4 inhibitors should be preferred.
Handling when unavoidable
If combined use is unavoidable, it is necessary to significantly reduce the dose of dasatinib and strengthen monitoring of electrocardiogram, liver and kidney function, and adverse reactions.
Invalid drug interval
Staggering medication timing cannot avoid interactions, as inhibitors have a long-term impact on enzyme activity and must be addressed at the level of drug selection or dosage.
Patients with severe liver and kidney dysfunction should be cautious or avoid using dasatinib; The combination with potent CYP3A4 inhibitors is a high-risk combination and should be avoided in principle. If unavoidable, it should be reduced and closely monitored. All adjustments must be made under the guidance of a doctor.
Disclaimer:《Dasatinib contraindicated population: severe liver and kidney dysfunction, risk of combination with potent CYP3A4 inhibitors》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Sprycel、Dasatinib、Spryce、Dasanix、达沙替尼、施达赛、依尼舒
Reference Price:$165.00
Prescribing Information: 达沙替尼(Dasatinib)是一种口服酪氨酸激酶抑制剂,通过靶向抑制BCR-ABL融合蛋白及SRC家族激酶(包括SRC、LCK、YES、FYN)等多种激酶活性发挥作用。 一、药品名称 1、通用名:达沙替尼 2、商品名:SPRYCEL® 二、适应症 1、成...